Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology

被引:4
|
作者
Watanabe, Yoshitaka [1 ,2 ]
Fujinaga, Shuichiro [1 ]
Endo, Amane [3 ]
Endo, Shota [1 ]
Nakagawa, Mayu [1 ]
Sakuraya, Koji [1 ]
机构
[1] Saitama Childrens Med Ctr, Div Nephrol, Chuo Ku, 1-2 Shintoshin, Saitama, Saitama 3308777, Japan
[2] Showa Univ, Childrens Med Ctr, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan
[3] Juntendo Univ, Dept Pediat & Adolescent Med, Tokyo, Japan
关键词
Initial steroid-resistant nephrotic syndrome; Immune-based etiology; Focal segmental glomerulosclerosis; Minimal change disease; Single disease spectrum; Children; SELECTIVITY; PROTEINURIA; DISEASE;
D O I
10.1007/s00467-020-04760-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Although many pediatric nephrologists consider focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) as separate clinical entities, whether the initial histology could affect clinical courses in children with steroid-resistant nephrotic syndrome (SRNS) suspected of having an immune-based etiology remains unknown, especially for long-term outcomes. Methods We retrospectively reviewed long-term outcomes (> 3 years; median follow-up, 9.1 years) of 21 children with initial SRNS (FSGS,N = 9; MCD,N = 12) who achieved complete remission with immunosuppressive agents, including cyclosporine. Results At NS onset, incidence of acute kidney injury (67% vs. 8%,P < 0.05) and proportion of patients with non-selective proteinuria (56% vs. 0%,P < 0.01) were significantly higher in the FSGS group than the MCD group. Furthermore, median days until complete remission after treatment was significantly longer in the FSGS group than the MCD group (116 days vs. 45 days,P < 0.001). Although subsequent biopsy histology of the 12 patients in the MCD group was still identical in all MCD, three of nine patients in the FSGS group were reclassified from FSGS to MCD at second biopsy. At last visit, all patients maintained complete remission, and none developed chronic kidney disease. Conclusions Initial presentation in the FSGS group was characterized by more severe clinical manifestations than the MCD group. If complete remission is achieved, FSGS and MCD in children with immune-mediated SRNS may constitute a single disease spectrum because the long-term outcomes are favorable, irrespective of initial histology.
引用
收藏
页码:2377 / 2381
页数:5
相关论文
共 50 条
  • [41] Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome
    Yuko Hamasaki
    Norishige Yoshikawa
    Shinzaburo Hattori
    Satoshi Sasaki
    Kazumoto Iijima
    Koichi Nakanishi
    Takeshi Matsuyama
    Kenji Ishikura
    Nahoko Yata
    Tetsuji Kaneko
    Masataka Honda
    Pediatric Nephrology, 2009, 24 : 2177 - 2185
  • [42] Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome
    Hamasaki, Yuko
    Yoshikawa, Norishige
    Hattori, Shinzaburo
    Sasaki, Satoshi
    Iijima, Kazumoto
    Nakanishi, Koichi
    Matsuyama, Takeshi
    Ishikura, Kenji
    Yata, Nahoko
    Kaneko, Tetsuji
    Honda, Masataka
    PEDIATRIC NEPHROLOGY, 2009, 24 (11) : 2177 - 2185
  • [43] Management and Outcome of Steroid-Resistant Nephrotic Syndrome in Children
    Otukesh, Hasan
    Otukesh, Salman
    Mojtahedzadeh, Mona
    Hoseini, Rozita
    Fereshtehnejad, Seyed-Mohammad
    Fard, Azam Riahi
    Sadigh, Nader
    Behzadi, Ashkan Heshmatzade
    Javadi, Ramila
    Hooman, Nakissa
    Mehrazma, Mitra
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2009, 3 (04) : 210 - 217
  • [44] Chlorambucil therapy in children with steroid-resistant nephrotic syndrome
    Kari, JA
    Alkushi, A
    Alshaya, HO
    SAUDI MEDICAL JOURNAL, 2006, 27 (04) : 558 - 559
  • [45] Management of steroid-resistant nephrotic syndrome in children and adolescents
    Tullus, Kjell
    Webb, Hazel
    Bagga, Arvind
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (12): : 880 - 890
  • [46] Immunosuppressive Therapy in Children With Steroid-Resistant Nephrotic Syndrome
    Li, Jing
    Li, Qin
    Lu, Jinmiao
    Li, Zhiping
    IRANIAN JOURNAL OF PEDIATRICS, 2018, 28 (01)
  • [47] Experience with tacrolimus in children with steroid-resistant nephrotic syndrome
    Butani, Lavjay
    Ramsamooj, Rajendra
    PEDIATRIC NEPHROLOGY, 2009, 24 (08) : 1517 - 1523
  • [48] TREATMENT OF STEROID-RESISTANT NEPHROTIC SYNDROME IN CHILDREN Abstracts
    不详
    ARCHIV EUROMEDICA, 2014, 4 (01): : 69 - 81
  • [49] Endothelial Dysfunction in Children with Steroid-Resistant Nephrotic Syndrome
    Kari, Jameela Abdulaziz
    Quinlan, Catherine
    Deanfield, John
    Shroff, Rukshana
    Tullus, Kjell
    IRANIAN JOURNAL OF PEDIATRICS, 2017, 27 (04)
  • [50] Body growth of children with steroid-resistant nephrotic syndrome
    K. Schärer
    Hans C. Essigmann
    Franz Schaefer
    Pediatric Nephrology, 1999, 13 : 828 - 834